Post by Cardior Pharmaceuticals

Cardior’s Managing Director, Prof. Thomas Thum, MD, PhD, will take the stage at the 22nd CVCT - Cardiovascular Clinical Trialists Forum on December 10 at 16:30 CET to present: “From Platform to Multinational Trials: Cardior’s Experience as a Blueprint for Cardiovascular RNA Therapeutic Development.” In this session, Thomas highlights Cardior’s journey advancing its lead candidate from early discovery phases to multinational clinical trials. We look forward to connecting with attendees at CVCT!